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Request of an opinion 
 
Rejection of the name Borreliella gen. nov. and all proposed species comb. nov. 
placed therein. Request for an opinion.  
 
Gabriele Margos, Brian Stevenson, Alexander Gofton, Charlotte Oskam, Agustin Estrada-Pena, Sally 





Rejection (nomen rejiciendum) of the name Borreliella gen. nov. and all new combinations therein is 
being requested on grounds of risk to human health and patient safety (Principle 1, subprinciple 2 and 
Rule 56a) and violation to aim for stability of names, avoid useless creation of names (Principle 1, 




The genus Borrelia, initially described by Swellengrebel 1907, was divided by Adeolu and 
Gupta (Adeolu and Gupta, 2014) into two genera, one retaining the name Borrelia (comprising 
largely species associated with tick-borne relapsing fever illnesses), the other named Borreliella 
gen. nov. containing species of the Borrelia burgdorferi sensu lato species complex (which 
cause Lyme borreliosis). Subsequent work showed that the genus separation was based on 
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insufficient data and the drawn conclusions are only supported by a subset of Borrelia species 
(Margos et al., 2017; Margos et al., 2018; Estrada-Peña and Cabezas-Cruz, 2019; Margos et al., 
2019). Following publication of the genus separation the names of eight out of 20 species were 
validated in the Validation List 163 (Oren and Garrity, 2015). In a later list (Oren and Garrity, 
2018) three further species were re-named. As this will generate confusion amongst medical 
practitioners and health professionals, and it may seriously affect human health and welfare.  
Risks to human health and patient safety 
Lyme borreliosis (also called Lyme disease) is the most common arthropod-borne bacterial 
disease of humans in North America and Europe affecting an estimated 300,000 people each 
year in the USA, and, according to health insurance data, over 200,000 cases of Lyme 
borreliosis occur every year in Germany alone (Steere, 2001; Stanek and Strle, 2009; Muller 
et al., 2012; Radolf et al., 2012; Nelson et al., 2015; Schwartz et al., 2017; Sykes and 
Makiello, 2017).  
Symptoms of Lyme borreliosis can vary widely among patients and may include characteristic 
skin lesions, arthritis, meningitis, radiculoneuritis, facial nerve paralysis, ocular involvement, 
and atrioventricular nodal block (Steere, 2001; Pinto, 2002; Stanek and Strle, 2003; Forrester 
and Mead, 2014; Hegerova and Olson, 2014; Kuchynka et al., 2015; Robinson et al., 2015). 
Notably, symptoms caused by some relapsing fever species, e.g. B. miyamotoi, may resemble 
that of Lyme borreliosis (Telford et al., 2015; Boden et al., 2016). Failure to treat this infection 
during the early stages can result in later severe clinical manifestations that may be more 
difficult to treat, such as Lyme arthritis and acrodermatitis chronica atrophicans. A missed or 
delayed diagnosis of Lyme carditis might even contribute to patient mortality (Steere, 2001; 
Stanek and Strle, 2003; Koene et al., 2012; Forrester and Mead, 2014; Shenthar et al., 2014; 
Yoon et al., 2015). Due to considerations of human health and welfare, we respectfully ask the 
Judicial Commission to reject Borreliella gen. nov. and all new combinations contained in it as 
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nomen periculosum, (as per Rule 56a of the International Code of Nomenclature of Prokaryotes) 
(Parker et al., 2015). Following this guidance, we describe safety concerns pertaining to 
changing the genus name of Lyme borreliosis-causing spirochetes: 
1. The names “Lyme borreliosis” and “Borrelia” are thoroughly intertwined in medical 
literature. It is imperative that physicians and other care givers receive prompt and 
accurate information when diagnosing and treating patients. New information on 
treatment recommendations or diagnostic tests is frequently published. From discovery 
onward, all publications on Lyme borreliosis describe the causative bacteria as members 
of the genus Borrelia. Only the paper on renaming the genus (Adeolu and Gupta, 2014), 
and few others, even mention the word “Borreliella.” 
2. Throughout the world, countless databases store diagnostic and treatment information. 
Search algorithms are usually based on keyword matches in order to retrieve the 
requested information. Thus, a search for Borreliella will likely fail to identify 
information that uses the name Borrelia, and vice versa. There is significant potential 
that such a failure could lead to diagnostic confusion and sub-optimal patient treatment, 
increasing the potential of poor outcomes for patients. Overcoming this problem would 
require replacement of every database and/or access program throughout the world, 
which is not a practical solution. The possible risk to human health far outweighs any 
benefit of the proposed bacterial species name change. 
3. In some countries, payment for the delivery of diagnostic testing services and clinical 
care to patients is highly dependent upon the use of standardized, precise disease codes 
and procedural codes (e.g. ICD-10, CPT in the USA). Such coding in hospitals, clinics, 
health care systems and insurance companies is indeed based on the terminology 
“Borrelia.” Inconsistencies in coding and related descriptors in computer systems, along 
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with debates about whether Borreliella burgdorferi is the same causative agent as 
Borrelia burgdorferi, present genuine risks of confusion, denial of claims, and delay in 
proper insurance coverage. Consequently, access to diagnosis and treatment may be 
compromised, which could endanger the patient’s health.  
4. Government regulations vary around the world. Similarly, health insurance coverages 
and procedures vary extensively. A diagnostic test or treatment regimen with approved 
use for treating infections by Borrelia burgdorferi sensu lato may not automatically be 
accepted for Borreliella burgdorferi. In such cases, a patient may be denied treatment 
or misdiagnosed. Again, this potential threat to human health needs to be of primary 
concern. 
5. Lyme borreliosis is a professional and public risk in many countries for persons using 
forested or grassy areas for work (eg. forestry) or recreation. Public health interventions 
including education materials rely heavily on the terminology Borrelia to properly 
inform the public and industry stakeholders about this pathogen, the risk of infection, 
and how to limit exposure. Specific diagnosis and treatment are often covered by 
professional insurance programs; debates about Borreliella as being the same as 
Borrelia has the potential to delay proper insurance coverage and, consequently, 
diagnosis and treatment. This endangers the patient’s health and – by consequence – 
further employment.  
   
Violation of Principle 1, subprinciple 1 and 3, and Principle 9 of the Code 
Although the International Code of Nomenclature of Prokaryotes (ICNP) is concerned mainly 
with taxonomical nomenclature, it is difficult to completely separate this from other 
taxonomical disciplines such as classification and characterization. The preface of the latest 
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edition of the Code holds that “While the Code does not attempt to interfere with the process 
of classification it does lay down clear rules that stipulate that taxa must be distinguishable, 
that types must be properly designated and (where appropriate) authentic strains must be 
made available without restriction, and that data on which descriptions are based must be 
included. The Code provides the critical links between nomenclature, classification and 
characterization…...”, we would like to raise some critical issues regarding the separation of 
the genus Borrelia affecting its nomenclatural changes.   
6. The genus Borrelia emend. Margos et al. 2018 currently comprises 42 named species 
(LPSN bacterio.net) including 21 species within the relapsing fever-associated group 
(RF), 20 species within the Lyme borreliosis-associated group (LB), and one species (B. 
turcica) within the novel reptile-associated group. However, there is a wide diversity of 
borreliae not represented by official named species (Mitani et al., 2004; Lin et al., 2005; 
Takano et al., 2011; Fedorova et al., 2014; Ivanova et al., 2014; Fingerle et al., 2016; 
Loh et al., 2017; Kumagai et al., 2018). Some of these novel Borrelia species 
phylogenetically cluster within previously characterized  borreliae lineages such as 
Candidatus Borrelia texasensis, Candidatus Borrelia kalaharica, and Borrelia sp. from 
Tanzania  in the argasid-transmitted RF clade, and B. chilensis in the Ixodes-transmitted 
LB clade (Mitani et al., 2004; Lin et al., 2005; Ivanova et al., 2014; Fingerle et al., 2016). 
However, more significant is the extensive diversity of Borrelia being described from 
metastriate ticks that form deeply branching unique monophyletic lineages within the 
genus. Such species include Candidatus Borrelia tachyglossi from echidnas (Loh et al., 
2017), several novel species from Testudines (Takano et al., 2011), lizards (Panetta et 
al., 2017; Kaenkan et al., 2019; Supriyono et al., 2019), and snakes (Takano et al., 2010), 
and two putative species associated with Haemaphysalis spp. and Asian deer (Kumagai 
et al., 2018). 
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The proposal by Adeolu and Gupta (2014) to splitting the genus Borrelia into two, 
Borrelia (relapsing-fever group spirochaetes) and a novel genus Borreliella (Lyme 
borreliosis group spirochaetes) (Adeolu and Gupta, 2014) left out all of the metastriate-
transmitted Borrelia species, the inclusion of which significantly alter our 
understanding of borreliae evolution.  
7. The authors described conserved signature indels (CSIs) and conserved signature 
proteins (CSPs) that could distinguish between the LB Borrelia and the RF Borrelia 
groups. The description of the new genera indicated that only these genetic markers are 
able to distinguish the two genera while there is overlap in morphology (e.g. helical 
cells, 0.2-0.3 μm in width, 3-180 μm in length [the latter being a mistake as cells of both 
groups are usually 10-30 μm in length]), phenotypic traits (e.g. motility via periplasmic 
flagella, microaerophily, vector-transmission) and genomic GC content (26-32 %) of 
the two groups. As we have previously pointed out, it is uncontested that differences in 
CSI and CSP exist between the clade of LB and RF species (Margos et al., 2018), there 
are similarities and overlaps in traits that need to be taken into consideration when 
studying taxonomy (Table). Apart from a common morphology that is shared by 
spirochetal bacteria (with some variations within groups, e.g. number of flagella, 
number and regularity of spirals), a similar genome structure, similar GC content, 
a further common property of species within the genus Borrelia is that they are 
with one exception maintained in natural transmission cycles by ticks as vector. 
Thus, it is our view that the renaming is based on selected genomic characters, i.e. on 
CSIs and CSPs in only two of the clades contributing to the genus Borrelia. In a third 
clade of species (e.g. B. turcica, Candidatus B. tachyglossi which have been subsumed 
under RF species by Gupta, 2019) 17-20% of these characters do not follow the 
predicted pattern of having RF specific CSIs but have a signature of LB CSIs. In our 
opinion this disregards principle 1 subprinciple 3 of the Code (‘Avoid the useless 
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creation of names’) and principle 9 (The name of a taxon should not be changed without 
sufficient reason….) and is in conflict with the statement in the preface (….it [the Code] 
does lay down clear rules that stipulate that taxa must be distinguishable…).  
8. Following division of the genus Borrelia into two separate genera, 14 species out of 20 
species were renamed in the new genus Borreliella (Adeolu and Gupta, 2014) and 11 
validated in IJSEM (Oren and Garrity, 2015; Oren and Garrity, 2018). We would like 
to highlight that in 2018 and 2019, two independent studies evaluated a justification of 
the genus separation (Margos et al., 2018; Estrada-Peña and Cabezas-Cruz, 2019). The 
first study sequenced the genomes of species “intermittent” between the relapsing fever 
clade and the B. burgdorferi s.l. clade, a reptile-associated and a newly described 
echidna-associated species (Gofton et al., 2018; Margos et al., 2018). Data based on the 
percentage of conserved proteins (POCP) (Qin et al., 2014) and on clustering of CSIs 
suggested that all groups should remain within a single genus (Margos et al., 2018). 
Independently, using a phyloproteomics approach the second study concluded that the 
separation of relapsing fever and Lyme borreliosis group spirochetes was not supported 
by their data (Estrada-Peña and Cabezas-Cruz, 2019). A recent review that included a 
phylogenetic analysis of near full length 16S rRNA sequences of all reported Borrelia 
species showed that many strains and species need to be evaluated before judgement is 
justified on the genus as a whole (Margos et al., 2019).  
 
Given the situation outline above, the proposed changes in Borrelia taxonomy, i.e. the creation 
of two different genera is a violation of principle 1, subprinciples 1 and 3 of the Code as the 
proposed changes are premature, i.e. based on insufficient data, which does not support stability 
of names (violation of subprinciple 1) and uselessly creates new names (subprinciple 3). The 
latest publication by Gupta (Gupta, 2019) on Borrelia taxonomy reiterates results of earlier 
studies and thus violates principle 9 of the Code which states that  “The name of a taxon should 
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not be changed without sufficient reason based either on further taxonomic studies or on the 
necessity of giving up a nomenclature that is contrary to the Rules of this Code.”  
The genus Borrelia is currently validated in its original form (Oren and Garrity, 2019) and 
other analyses such as proteomics, analyses of phenotypic and ecological data are consistent 
with this view (Margos et al., 2019). For this and the reasons outlined above we would like to 
ask the Judicial Commission to support the rejection of the name Borreliella gen. nov. and all 
combinations therein.     
Table Borrelia – key features of clades 
Clade Borrelia burgdorferi 
sensu lato 





Morphology* motile spirochaetal 
bacteria, helically 











0.2 – 0.3 μm diameter 
10-30 μm in length   
motile spirochaetal 
bacteria, helically 











0.2-0.5 μm diameter 
10-40 μm in length   
motile spirochaetal 
bacteria, helically 
shaped with tapered 
ends; 
 periplasmic flagellae 
(n=10); 
0.2 – 0.3 μm diameter 
10-25 μm in length   
Genomic features* Fragmented genome, 
Linear chromosome, 
plasmids (5-70 kb) 
Size 1.5 Mb 
GC content 28%; 
common ancestry of 
plasmids cp26 (all LB) 
and lpB (B. miyamotoi) 
Fragmented genome, 
linear chromosome, 
plasmids (5-165 kb),  
Size 1.5 Mb 
GC content 27-30%; 
common ancestry of 
plasmids cp26 (all LB) 




Size 1.5 Mb 
GC content 30% 










Soft tick genera 
Ornithodoros, Argas; 
body louse Pediculus 
humanus#;  
 
Pathogenicity profile* Commonly tissue 
pathogens, transient 
blood phase except in 
B. mayonii (blood 
densities up to 105 – 
106 cells / ml). 
Commonly found in 
blood before/during 
febrile periods but 
colonize also tissue. 
For many unknown. B. 
duttonii is well known 
to cross the placenta 
causing peri-natal 
mortality; 
B. miyamotoi infection 





rare, shown for B. 
afzelii§ 
common unknown  
*information is available only for a subset of species, not for all species. 
#the louse may not be considered a proper vector because transmission occurs when the louse is 
crushed and gut content is smeared into the skin 
§ (van Duijvendijk et al., 2016) 
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